Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0374019940170030197
Ewha Medical Journal
1994 Volume.17 No. 3 p.197 ~ p.204
Prevalence of Antibody to Hepatitis C Virus(antiHCV) with Detection of HCV-RNA by Polymerase Chain Reaction(PCR) in End Stage Renal Disease Patients on Hemodialysis




Abstract
patients undergoing maintenance hemodialysis(HD) potentially have an increased risk of exposure to viral hepatitis. The reported prevalence of antiHCV in hemodialysis patients varied widely form 7.6-54% according to dialysis center and there were
many
reports that showed the correlation between the prevalence of antiHCV and duration of HD or transfusion amount.
Fifty-four patients on regular hemodialysis at our hospital were evaluated for the presence of hepatitic C antibody(antiHCV) with the comparison of various parameters such as duration of HD, amount of transfusion, AntiHCV using second-generation
enzyme
linked immunosorbant assay were found in six of 54 HD patients (11.1%). Among six antiHCV(+) patients, four patients were found to have HCV-RNA in their plasma detected by PCR. The percent of male patients were significantly higher in antiHCV(+)
group
(66.7 vs. 31.3%, P<0.05). The positivity of anti-HCV did not correlated with the duration of HD and amount of transfusion (P>0.05), but there was significant correlation with inceased alanine aminotransferase(P<0.05). While the prevalence
increased
over
2 years(5.9% in 1991. 11.1% in 1993) and HBsAg prevalence remained unchanged(9.8% in 1991, 9.3% in 1993).
Therefore, regular follow-up of liver function test and use of separate machine for antiHCV positive patients may be needed to prevent the transmission of hepatitis C virus during the hemodialysis proses itself.
KEYWORD
FullTexts / Linksout information
Listed journal information